CAS 1953157-39-5

Formel: C17H16ClN3O4

InChl: InChI=1S/C17H16ClN3O4/c1-9-3-4-13(20-19-9)10(2)24-16-8-15-11(7-12(16)18)14(21-25-15)5-6-17(22)23/h3-4,7-8,10H,5-6H2,1-2H3,(H,22,23)/t10-/m1/s1

InChI Key: YWASLAPMFGBZQP-SNVBAGLBSA-N

SMILES: CC1=NN=C(C=C1)[C@@H](C)OC2=C(C=C3C(=C2)ON=C3CCC(=O)O)Cl

GSK 366

CAS: 1953157-39-5

GSK 366

Formel: C₁₇H₁₆ClN₃O₄

Reinheit: 99.80%

Molekulargewicht: 361.78

Ref: 54-OR1106553

GSK 366

CAS: 1953157-39-5

Reinheit: 99.80%

Ref: IN-DA01NATR

GSK 366

CAS: 1953157-39-5

GSK 366 is a potent kynurenine-3-monooxygenase (KMO) inhibitor (IC50s: 0.7 nM and 2.3 nM for P. fluorescens-KMO and human KMO).

Formel: C₁₇H₁₆ClN₃O₄

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 361.78

Ref: TM-T11470